{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:45:24Z","timestamp":1780677924487,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ophtha.2007.01.040","type":"journal-article","created":{"date-parts":[[2008,1,12]],"date-time":"2008-01-12T12:20:42Z","timestamp":1200140442000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cost-effectiveness of Treating Ocular Hypertension"],"prefix":"10.1016","volume":"115","author":[{"given":"William C.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasiem J.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko A.","family":"Mychaskiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.01.040_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib2","series-title":"Strategies in Pharmacoeconomics and Outcomes Research","author":"Rychlik","year":"2002"},{"key":"10.1016\/j.ophtha.2007.01.040_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3111\/200508065084","article-title":"Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five European countries: Austria, France, Germany, the Netherlands and the United Kingdom","volume":"8","author":"Le Pen","year":"2005","journal-title":"J Med Econ"},{"key":"10.1016\/j.ophtha.2007.01.040_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.ijg.0000184834.93535.0b","article-title":"Clinical outcomes of glaucoma treatments over a patient lifetime: a Markov model","volume":"14","author":"Nordmann","year":"2005","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.01.040_bib5","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1185\/030079905X65592","article-title":"A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy","volume":"21","author":"Christensen","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2007.01.040_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005650-200006000-00004","article-title":"One thousand health-related quality-of-life estimates","volume":"38","author":"Tengs","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.ophtha.2007.01.040_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1755-3768.1987.tb08492.x","article-title":"Early diagnosis of glaucoma","volume":"65","author":"Odberg","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2007.01.040_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1755-3768.1974.tb01118.x","article-title":"Tonography and glaucomatous optic nerve damage","volume":"52","author":"Pohjanpelto","year":"1974","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.ophtha.2007.01.040_bib12","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/archopht.1978.03910060511007","article-title":"Quantitative visual field and optic disc correlates early in glaucoma","volume":"96","author":"Hart","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archopht.122.1.17","article-title":"Central corneal thickness as a risk factor for advanced glaucoma damage","volume":"122","author":"Herndon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9394(03)00484-7","article-title":"Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy","volume":"136","author":"Medeiros","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/jop.2006.22.26","article-title":"Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma","volume":"22","author":"Stewart","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.01.040_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ajo.2004.12.056","article-title":"Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma","volume":"139","author":"Martus","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajo.2006.01.019","article-title":"Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study","volume":"141","author":"Kymes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.123.10.1351","article-title":"Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma","volume":"123","author":"Medeiros","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-141-2-200407200-00013","article-title":"Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease","volume":"141","author":"Song","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2007.01.040_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-141-9-200411020-00011","article-title":"Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction","volume":"141","author":"Lee","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2007.01.040_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/112067219700700409","article-title":"Risk factors in ocular hypertension","volume":"7","author":"Georgopoulos","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.01.040_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/09286589609080113","article-title":"Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma Case-Control Study","volume":"3","author":"Leske","year":"1996","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T01:24:19Z","timestamp":1711502659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0161642007002138"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.040","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of Treating Ocular Hypertension","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}